Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Vincristine-induced nociceptive painful sensation, may be due to its potential of antioxidative, neuroprotective and calcium channel inhibitory action.Vincristine can treat MM, ERK1/2, Akt, and NF-κB inhibitors are potentially useful as anti-MDR agents for the treatment of Vincristine-resistant MM. An inherited polymorphism in the promoter region of CEP72 was associated with increased risk and severity of Vincristine-related peripheral neuropathy.
説明 | Vincristine-induced nociceptive painful sensation, may be due to its potential of antioxidative, neuroprotective and calcium channel inhibitory action.Vincristine can treat MM, ERK1/2, Akt, and NF-κB inhibitors are potentially useful as anti-MDR agents for the treatment of Vincristine-resistant MM. An inherited polymorphism in the promoter region of CEP72 was associated with increased risk and severity of Vincristine-related peripheral neuropathy. |
植物由来 |
分子量 | 824.96 |
分子式 | C46H56N4O10 |
CAS No. | 57-22-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 12 mg/mL (14.55 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Vincristine 57-22-7 Cytoskeletal Signaling MAPK NF-Κb PI3K/Akt/mTOR signaling mTOR JNK Akt p38 MAPK NF-κB ERK NSC 67574 Inhibitor NSC67574 Antibiotic inhibit 22-Oxovincaleukoblastine NSC-67574 Microtubule/Tubulin Leurocristine inhibitor